Showing 19,001 - 19,020 results of 20,793 for search '"Therapy"', query time: 0.09s Refine Results
  1. 19001

    DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation by B. Dhakal, A. D’Souza, M. Pasquini, W. Saber, T. S. Fenske, R. B. Moss, W. R. Drobyski, P. Hari, M. Z. Abidi

    Published 2016-01-01
    “…Currently, there are no proven effective therapies. We report the use of inhaled DAS181, a novel sialidase fusion protein, for treatment of PIV type 3 pneumonia in two allogeneic hematopoietic SCT recipients with respiratory failure.…”
    Get full text
    Article
  2. 19002

    Importance of clinical trials and contributions to contemporary medicine: commentary by Haofuzi Zhang, Xiaofan Jiang

    Published 2025-12-01
    “…They contribute to public health improvements, reduce healthcare costs, uncover new understandings of disease biology, and facilitate the development of therapies for rare conditions. Investing in clinical trials is therefore essential for advancing medical science and enhancing patient outcomes globally.…”
    Get full text
    Article
  3. 19003

    Current Status of Gout Arthritis: Current Approaches to Gout Arthritis Treatment: Nanoparticles Delivery Systems Approach by Yedi Herdiana, Yoga Windhu Wardhana, Insan Sunan Kurniawansyah, Dolih Gozali, Nasrul Wathoni, Ferry Ferdiansyah Sofian

    Published 2025-01-01
    “…A new development in the approach to gout is that of NLRP3-targeted biologic agents, such as monoclonal therapies, to provide more accurate treatment by blocking specific pro-inflammatory cytokines. …”
    Get full text
    Article
  4. 19004

    A Behcet’s Disease Patient with Right Ventricular Thrombus, Pulmonary Artery Aneurysms, and Deep Vein Thrombosis Complicating Recurrent Pulmonary Thromboembolism by Selvi Aşker, Müntecep Aşker, Özgür Gürsu, Rıdvan Mercan, Özgür Bülent Timuçin

    Published 2013-01-01
    “…At the controls after three months of immunosuppressive and anticoagulant therapies, some clinical and radiological improvements were recognized. …”
    Get full text
    Article
  5. 19005

    Activator Protein-1 Transcriptional Activity Drives Soluble Micrograft-Mediated Cell Migration and Promotes the Matrix Remodeling Machinery by Martina Balli, Jonathan Sai-Hong Chui, Paraskevi Athanasouli, Willy Antoni Abreu de Oliveira, Youssef El Laithy, Maurilio Sampaolesi, Frederic Lluis

    Published 2019-01-01
    “…Impaired wound healing and tissue regeneration have severe consequences on the patient’s quality of life. Micrograft therapies are emerging as promising and affordable alternatives to improve skin regeneration by enhancing the endogenous wound repair processes. …”
    Get full text
    Article
  6. 19006
  7. 19007

    Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events by Li Chen, Iulian Pruteanu-Malinici, Anahita Dastur, Xunqin Yin, Dennie Frederick, Ruslan I. Sadreyev, Cyril H. Benes

    Published 2025-01-01
    “…Many resistance events to targeted therapies have been identified, suggesting a complex path to improve therapeutics. …”
    Get full text
    Article
  8. 19008

    Synergistic effect of inhibiting CHK2 and DNA replication on cancer cell growth by Flavie Coquel, Sing-Zong Ho, Keng-Chang Tsai, Chun-Yen Yang, Antoine Aze, Julie Devin, Ting-Hsiang Chang, Marie Kong-Hap, Audrey Bioteau, Jerome Moreaux, Domenico Maiorano, Philippe Pourquier, Wen-Chin Yang, Yea-Lih Lin, Philippe Pasero

    Published 2025-01-01
    “…This feature is exploited by cancer therapies to either increase RS to unbearable levels or inhibit checkpoint kinases involved in the DNA damage response. …”
    Get full text
    Article
  9. 19009

    A Survey of Insulin-Dependent Diabetes—Part II: Control Methods by Daisuke Takahashi, Yang Xiao, Fei Hu

    Published 2008-01-01
    “…We survey blood glucose control schemes for insulin-dependent diabetes therapies and systems. These schemes largely rely on mathematical models of the insulin-glucose relations, and these models are typically derived in an empirical or fundamental way. …”
    Get full text
    Article
  10. 19010

    Exploring the Revolutionary Impact of YAP Pathways on Physical and Rehabilitation Medicine by Carmelo Pirri

    Published 2025-01-01
    “…However, the detailed molecular pathways through which these therapies interact with tissues and influence gene expression are not yet fully understood. …”
    Get full text
    Article
  11. 19011
  12. 19012

    Glioblastoma Multiforme Stem Cells by Irena Dimov, Deasanka Tasic-Dimov, Irena Conic, Vladisav Stefanovic

    Published 2011-01-01
    “…There are promising mounting data on providing new molecular targets and predictive markers of response, leading to more effective therapies of GBM, guided by patient-specific genetic and epigenetic profiling. …”
    Get full text
    Article
  13. 19013

    Methods and Models for Metabolic Assessment in Mice by G. Pacini, B. Omar, B. Ahrén

    Published 2013-01-01
    “…The development of new therapies for the treatment of type 2 diabetes requires robust, reproducible and well validated in vivo experimental systems. …”
    Get full text
    Article
  14. 19014
  15. 19015

    Advances in Research Related to MicroRNA for Diabetic Retinopathy by Yahan Luo, Chunxia Li

    Published 2024-01-01
    “…Meanwhile, this article also discusses the research progress and application of miRNA-specific therapies for DR.…”
    Get full text
    Article
  16. 19016

    In vivo Ultrasonographic Evaluation of Patellar Tendon Stiffness after Anterior Cruciate Ligament Reconstruction with Patellar Tendon Autograft by Hsin-Yi Liu, Troy Blackburn, Darin Padua, R. Alexander Creighton, Paul Weinhold

    Published 2011-01-01
    “…Background: Tendon mechanical properties have been used to evaluate the effects of therapies on the healing of animal tendons, but these measures have not been convenient to record in vivo in humans due to their invasive nature. …”
    Get full text
    Article
  17. 19017

    Experiences of and response to the COVID-19 pandemic at private retail pharmacies in Kenya: a mixed-methods study by Edwine Barasa, Sassy Molyneux, Jacinta Nzinga, Audrey Mumbi, Peter Mwangi Mugo, Daniella Munene, Collins Jaguga, Davy Odhiambo, Elizabeth Ominde-Ogaja, Mercy Maina, Michael Mungoma, Nadia Butt, Sultani Matendechero, Titus Kahiga, Eric Sedah, Sylvia Opanga

    Published 2022-06-01
    “…For treatment of simulated clients, most pharmacies (71%, 73 of 103) recommended alternative therapies and nutritional supplements such as vitamin C; the rest recommended conventional therapies such as antibiotics. …”
    Get full text
    Article
  18. 19018

    The Influence of PK/PD on the Structure of Optimal Controls in Cancer Chemotherapy Models by Urszula Ledzewicz, Heinz Schättler

    Published 2005-07-01
    “…Results on scheduling optimal therapies when the controls represent the effectiveness of chemotherapeutic agents, or, equivalently, when the simplifying assumption is made that drugs act instantaneously, are compared with more realistic models that include pharmacokinetic (PK) equations modelling the drug's plasma concentration and various pharmacodynamic (PD) models for the effect the concentrations have on cells.…”
    Get full text
    Article
  19. 19019

    Ulcerated Scrotal Hemangioma in an 18-Month-Old Male Patient: A Case Report and Review of the Literature by Ioannis Patoulias, Konstantinos Farmakis, Christos Kaselas, Dimitrios Patoulias

    Published 2016-01-01
    “…The aim of this case report is to illustrate the challenges of scrotal hemangiomas pose and their potential therapies based on the successful surgical treatment of an ulcerated scrotal hemangioma in an 18-month-old male patient.…”
    Get full text
    Article
  20. 19020

    Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma by Michael Dolph, Gabriel Tremblay, Adrienne M Gilligan, Hoyee Leong

    Published 2021-08-01
    “…**Discussion:** Results for XVd were more favorable in 2L, having a higher probability of being a top 5 regimen, compared with 3L+ therapies based on the reported clinical trial results. …”
    Get full text
    Article